| 发明名称 | Sulforaphane for treating or reducing insulin resistance of the liver | ||
| 摘要 | The present invention provides sulforaphane, or a plant extract comprising sulforaphane, for treating or reducing insulin resistance of the liver. Especially, there is provided sulforaphane, or a plant extract comprising sulforaphane, for treating or reducing insulin resistance of the liver, wherein, in the subject to be treated, the insulin resistance index of the liver is higher than the insulin resistance of other metabolic tissue. | ||
| 申请公布号 | US9597307(B2) | 申请公布日期 | 2017.03.21 |
| 申请号 | US201314443907 | 申请日期 | 2013.11.19 |
| 申请人 | Rosengren Anders;Axelsson Annika | 发明人 | Rosengren Anders;Axelsson Annika |
| 分类号 | A61K31/26;A61K36/31 | 主分类号 | A61K31/26 |
| 代理机构 | Honigman Miller Schwartz and Cohn LLP | 代理人 | Honigman Miller Schwartz and Cohn LLP ;Day Noel E.;Budde Anna M. |
| 主权项 | 1. A method of treating or reducing insulin resistance of the liver and/or improving hepatic insulin sensitivity wherein, the mammal to be treated, has an insulin resistance index of the liver that is higher than the insulin resistance index of other metabolic tissue, the method comprising the step of administering an effective amount of sulforaphane, or a plant extract comprising an effective amount of sulforaphane, to a mammal in need thereof. | ||
| 地址 | Malmö SE | ||